Screener
Ocular Therapeutix OCUL Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 11,212 | 10,855 |
| Total current assets | 705,995 | 782,129 |
| Property and equipment, net | 18,425 | 19,676 |
| Restricted cash | 1,614 | 1,614 |
| Operating lease assets | 6,495 | 4,638 |
| Total assets | $732,529 | $808,057 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's restricted cash?
- Ocular Therapeutix (OCUL) reported restricted cash of $1.61M in Q1 2026.
- How has Ocular Therapeutix's restricted cash changed year-over-year?
- Ocular Therapeutix's restricted cash decreased by 0.0% year-over-year, from $1.61M to $1.61M.
- What is the long-term trend for Ocular Therapeutix's restricted cash?
- Over 5 years (2020 to 2025), Ocular Therapeutix's restricted cash has grown at a -1.8% compound annual growth rate (CAGR), from $1.76M to $1.61M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Ocular Therapeutix's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude